Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $457.20 | 1 | 56.5% |
| Food and Beverage | $352.54 | 8 | 43.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $555.25 | 3 | $0 (2022) |
| Medtronic Vascular, Inc. | $105.84 | 2 | $0 (2018) |
| PFIZER INC. | $102.13 | 2 | $0 (2019) |
| Novo Nordisk Inc | $34.54 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $11.98 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $555.25 | 3 | ABBVIE INC. ($555.25) |
| 2019 | $48.70 | 2 | Novo Nordisk Inc ($34.54) |
| 2018 | $117.82 | 3 | Medtronic Vascular, Inc. ($105.84) |
| 2017 | $87.97 | 1 | PFIZER INC. ($87.97) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2022 | ABBVIE INC. | UBRELVY (Drug) | Travel and Lodging | In-kind items and services | $457.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $84.34 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $34.54 | General |
| Category: Diabetes | ||||||
| 01/08/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 08/01/2018 | Medtronic Vascular, Inc. | ClosureFast (Device) | Food and Beverage | In-kind items and services | $89.00 | General |
| Category: EndoVenous Therapies | ||||||
| 08/01/2018 | Medtronic Vascular, Inc. | ClosureFast (Device) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: EndoVenous Therapies | ||||||
| 06/07/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $87.97 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 108 | 160 | $20,921 | $15,012 |
| 2022 | 5 | 146 | 192 | $23,728 | $16,661 |
| 2021 | 4 | 134 | 183 | $22,964 | $16,968 |
| 2020 | 4 | 141 | 171 | $18,344 | $10,674 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 94 | $14,100 | $9,158 | 64.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 32 | 32 | $4,800 | $4,179 | 87.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 15 | 15 | $1,223 | $1,051 | 85.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $798.00 | $624.53 | 78.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 95 | $14,250 | $8,705 | 61.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $4,950 | $4,508 | 91.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 23 | 25 | $1,983 | $1,662 | 83.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 12 | $1,368 | $906.97 | 66.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 27 | $1,177 | $878.55 | 74.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 104 | $15,600 | $10,512 | 67.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 34 | 34 | $5,100 | $4,725 | 92.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 22 | 22 | $1,298 | $1,298 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $966.00 | $433.09 | 44.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 45 | 75 | $11,250 | $5,167 | 45.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 23 | 23 | $3,450 | $2,799 | 81.1% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 34 | 34 | $2,006 | $1,994 | 99.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 39 | 39 | $1,638 | $714.54 | 43.6% |
About Dr. Jane Neuman, M.D
Dr. Jane Neuman, M.D is a Internal Medicine healthcare provider based in Oakhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811092695.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jane Neuman, M.D has received a total of $809.74 in payments from pharmaceutical and medical device companies, with $555.25 received in 2022. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($457.20).
As a Medicare-enrolled provider, Neuman has provided services to 529 Medicare beneficiaries, totaling 706 services with total Medicare billing of $59,316. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Oakhurst, NJ
- Active Since 09/14/2006
- Last Updated 06/02/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1811092695
Products in Payments
- UBRELVY (Drug) $541.54
- ClosureFast (Device) $105.84
- EUCRISA (Drug) $87.97
- Ozempic (Drug) $34.54
- LYRICA (Drug) $14.16
- QULIPTA (Drug) $13.71
- NUCALA (Biological) $11.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Oakhurst
Dr. John Ciciarelli, Md, MD
Internal Medicine — Payments: $42,609
Dr. Aleksey Kretov, Md, MD
Internal Medicine — Payments: $18,333
Charles Peeples, Md, MD
Internal Medicine — Payments: $9,690
Dr. Richard Mojares, M.d, M.D
Internal Medicine — Payments: $6,285
Dr. Dharmesh Kaswala, Md, MD
Internal Medicine — Payments: $6,113
Reza Akhtar, Md, MD
Internal Medicine — Payments: $6,097